Telemetry Investments’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,043
| Closed | -$154K | – | 174 |
|
|
2022
Q2 | $154K | Sell |
11,043
-7,968
| -42% | -$111K | 0.18% | 110 |
|
|
2022
Q1 | $328K | Sell |
19,011
-10,989
| -37% | -$190K | 0.52% | 67 |
|
|
2021
Q4 | $436K | Sell |
30,000
-1,500
| -5% | -$21.8K | 0.56% | 58 |
|
|
2021
Q3 | $567K | Sell |
31,500
-2,518
| -7% | -$45.3K | 0.76% | 42 |
|
|
2021
Q2 | $597K | Buy |
34,018
+24,018
| +240% | +$422K | 0.82% | 46 |
|
|
2021
Q1 | $252K | Sell |
10,000
-36,800
| -79% | -$927K | 0.28% | 105 |
|
|
2020
Q4 | $303K | Sell |
46,800
-220,666
| -83% | -$1.43M | 0.51% | 57 |
|
|
2020
Q3 | $687K | Sell |
267,466
-206,449
| -44% | -$530K | 1.49% | 28 |
|
|
2020
Q2 | $768K | Sell |
473,915
-27,085
| -5% | -$43.9K | 2.09% | 15 |
|
|
2020
Q1 | $521K | Buy |
501,000
+60,000
| +14% | +$62.4K | 1.82% | 22 |
|
|
2019
Q4 | $833K | Buy |
441,000
+226,407
| +106% | +$428K | 2.78% | 11 |
|
|
2019
Q3 | $232K | Buy |
214,593
+25,063
| +13% | +$27.1K | 0.67% | 37 |
|
|
2019
Q2 | $415K | Buy |
189,530
+40,526
| +27% | +$88.7K | 0.32% | 36 |
|
|
2019
Q1 | $893K | Buy |
149,004
+50,504
| +51% | +$303K | 0.45% | 15 |
|
|
2018
Q4 | $728K | Buy |
98,500
+56,500
| +135% | +$418K | 0.46% | 34 |
|
|
2018
Q3 | $610K | Buy |
42,000
+6,000
| +17% | +$87.1K | 0.28% | 30 |
|
|
2018
Q2 | $719K | Sell |
36,000
-20,000
| -36% | -$399K | 0.27% | 31 |
|
|
2018
Q1 | $981K | Buy |
+56,000
| New | +$981K | 0.37% | 30 |
|